|
|
This site is an historical archive of the
original CIRAR P20 web site.
RETURN to the current active CIRAR web site.
AIMS of the CIRAR
| While much progress has been made
to control preventable infectious diseases, infections remain a major
cause of morbidity and mortality. Many of the traditional
treatments for common infections are no longer effective because of
the fast-growing problem of antimicrobial resistance, first associated
with hospitals, but increasingly widespread in the community.
Antibiotic resistance is now a global problem of major concern.
The ultimate goal of this Center for Interdisciplinary Research on
Antimicrobial Resistance (CIRAR) is to develop strategies to implement
and evaluate a long term collaborative program of interdisciplinary
research on reducing antimicrobial resistance.
The specific aims of the CIRAR are to:
- Plan, implement, and evaluate
outcomes of a core program and curriculum to prepare biomedical
researchers to conduct interdisciplinary research;
- Develop the expertise of CIRAR
investigators in interdisciplinary research;
- Conduct interdisciplinary
demonstration projects related to the prevention and control of
antimicrobial resistance and evaluate their outcomes;
- Implement dissemination and
implementation strategies that assure the sustainability and
expansion of CIRAR's interdisciplinary research projects and
programs; and
- Formalize plans for a sustainable
Interdisciplinary Research Consortium for Antimicrobial Resistance.
| The first component of the Center is the
development and implementation of formal training for conducting
interdisciplinary research which will be incorporated into several
ongoing programs within Columbia University and made available by
internet. In Years 2 and 3, the interdisciplinary research
curriculum will be further disseminated.
The second CIRAR component is the development of
interdisciplinary demonstration projects designed to rationalize
antimicrobial use and reduce antimicrobial resistance. In the
final year, plans for a sustainable Consortium on antimicrobial
resistance will be formalized. |

February 1, 2007 CIRAR monthly
meeting. |
|
|